Carlisle Companies Incorporated (CSL)

Current ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total current assets US$ in thousands 1,926,300 2,911,400 3,152,100 3,463,400 3,408,100 3,657,000 379,300 2,152,300 2,245,000 2,770,900 2,532,600 2,228,800 2,150,900 2,081,800 2,512,500 2,144,500 2,209,300 2,140,200 2,152,900 2,608,600
Total current liabilities US$ in thousands 665,800 1,068,400 1,089,700 1,174,700 1,186,300 875,600 1,045,300 930,000 1,078,400 1,552,100 1,259,700 1,188,600 1,169,500 851,300 761,700 660,100 646,200 645,700 613,900 602,700
Current ratio 2.89 2.73 2.89 2.95 2.87 4.18 0.36 2.31 2.08 1.79 2.01 1.88 1.84 2.45 3.30 3.25 3.42 3.31 3.51 4.33

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,926,300K ÷ $665,800K
= 2.89

The current ratio of Carlisle Companies Incorporated has exhibited fluctuations over the past few years. The current ratio measures the company's ability to cover its short-term obligations with its current assets. From March 31, 2020, through March 31, 2021, the company maintained a relatively high current ratio above 3, indicating a healthy liquidity position.

However, starting from the third quarter of 2021, the current ratio began to decline, reaching a low of 0.36 on June 30, 2023. This sharp decrease suggests potential difficulties in meeting short-term obligations with current assets during that period.

From September 30, 2023, the current ratio improved significantly, reaching a high of 4.18, indicating a strong liquidity position and potential ease in meeting short-term obligations. Despite some fluctuations, the current ratio stabilized around 2.89 to 3.00 in the last few quarters of 2024, indicating a relatively healthy liquidity position for the company.

Overall, monitoring the current ratio of Carlisle Companies Incorporated is crucial as it provides insights into the company's liquidity and ability to manage short-term financial obligations efficiently.


Peer comparison

Dec 31, 2024

Company name
Symbol
Current ratio
Carlisle Companies Incorporated
CSL
2.89
West Pharmaceutical Services Inc
WST
2.79